Cargando…

Evaluation of health utility in trial-based cost–utility analyses for major cardiovascular disease: protocol for a systematic review

INTRODUCTION: The global incidence of cardiovascular disease (CVD) is high, and the medical costs associated with its management have been increasing. Cost–utility analyses (CUAs) are essential for understanding the value of healthcare interventions and for decision-making. A majority of the CUAs fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakao, Yasuhisa, Kawakami, Hiroshi, Miyazaki, Shigehiro, Saito, Makoto, Luo, Yan, Yamamoto, Kazumichi, Yamaguchi, Osamu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173991/ https://www.ncbi.nlm.nih.gov/pubmed/37160387 http://dx.doi.org/10.1136/bmjopen-2022-067045

Ejemplares similares

Protocol for development of an assessment tool for competency of ECG interpretation: expert consensus by the RAND/UCLA appropriateness method and cross-sectional testing using multidimensional item response theory
por: Inaba, Shinji, et al.
Publicado: (2023)

Atrial fibrillation activation patterns predict freedom from arrhythmias after catheter ablation: utility of ExTRa mapping™
por: Aoyama, Daisetsu, et al.
Publicado: (2023)

Real-world utilization of guideline-directed genetic testing in inherited cardiovascular diseases
por: Longoni, Mauro, et al.
Publicado: (2023)

Visualization of Cardiac Perforation During Micra Transcatheter Leadless Pacemaker Implantation　― A Lesson From Cadaver Training ―
por: Nakao, Yasuhisa, et al.
Publicado: (2020)

Validation and Utilization of a Clinical Next-Generation Sequencing Panel for Selected Cardiovascular Disorders
por: Celestino-Soper, Patrícia B. S., et al.
Publicado: (2017)

The Utility of Advanced Cardiovascular Imaging in Cancer Patients—When, Why, How, and the Latest Developments
por: Yu, Christopher, et al.
Publicado: (2021)

Unexpected and recurrent left atrial thrombus after chemoradiotherapy for oesophageal cancer
por: Nakao, Yasuhisa, et al.
Publicado: (2023)

Cost Utility Analysis of Multidisciplinary Postacute Care for Stroke: A Prospective Six-Hospital Cohort Study
por: Chen, Yu-Ching, et al.
Publicado: (2022)

Primary vs. Secondary Heart Failure Diagnosis: Differences in Clinical Outcomes, Healthcare Resource Utilization and Cost
por: Bueno, Héctor, et al.
Publicado: (2022)

Using Published Health Utilities in Cost-Utility Analyses: Discrepancies and Issues in Cardiovascular Disease
por: Zhou, Ting, et al.
Publicado: (2021)

Diabetes and Its Cardiovascular Complications: Comprehensive Network and Systematic Analyses
por: Wu, Hao, et al.
Publicado: (2022)

Age-Related Utilization of Thrombus Aspiration in Patients With ST-Segment Elevation Myocardial Infarction: Findings From the Improving Care for Cardiovascular Disease in China Project
por: Qu, Yang-Yang, et al.
Publicado: (2022)

No dose-response relationship of clarithromycin utilization on cardiovascular outcomes in patients with stable coronary heart disease: Analysis of Taiwan’s national health insurance claims data
por: Yu, Ben-Hui, et al.
Publicado: (2022)

Utility of Non-invasive Cardiac Imaging Assessment in Coronavirus Disease 2019
por: Hothi, Sandeep S., et al.
Publicado: (2021)

The RECARDINA Study protocol: diagnostic utility of ultra-abbreviated echocardiographic protocol for handheld machines used by non-experts to detect rheumatic heart disease
por: Francis, Joshua Reginald, et al.
Publicado: (2020)

The critical issue linking lipids and inflammation: Clinical utility of stopping oxidative stress
por: Bale, Bradley Field, et al.
Publicado: (2022)

Sex differences in patterns of referral and resource utilization in the cardiology clinic: an outpatient analysis
por: Vicent, Lourdes, et al.
Publicado: (2023)

Protocol for the ROBUST (Registry Of type B aortic dissection with the Utility of STent graft) study: an ambispective, multicentre, open cohort study
por: Rong, Dan, et al.
Publicado: (2017)

microRNAs as biomarkers of risk of major adverse cardiovascular events in atrial fibrillation
por: de los Reyes-García, Ascensión M., et al.
Publicado: (2023)

The polypill in the primary prevention of cardiovascular disease: cost-effectiveness in the Dutch population
por: van Gils, Paul F, et al.
Publicado: (2011)

Predicting major adverse cardiovascular events for secondary prevention: protocol for a systematic review and meta-analysis of risk prediction models
por: Akyea, Ralph K, et al.
Publicado: (2020)

Restricted left atrial dilatation can visually differentiate cardiac amyloidosis from hypertrophic cardiomyopathy
por: Higashi, Haruhiko, et al.
Publicado: (2021)

Clinical Utility of Fluid Volume Assessment in Heart Failure Patients Using Bioimpedance Spectroscopy
por: Accardi, Andrew J., et al.
Publicado: (2021)

Frequency of Bioprosthetic Valve Fracturing Utilization in an All-Comers Valve-in-Valve TAVR Cohort
por: Ruge, Hendrik, et al.
Publicado: (2021)

Identification of mitophagy-related genes with potential clinical utility in myocardial infarction at transcriptional level
por: Yang, Zhikai, et al.
Publicado: (2023)

Incremental predictive utility of a radiomics signature in a nomogram for the recurrence of atrial fibrillation
por: Zheng, Dongyan, et al.
Publicado: (2023)

Shared Genetic Liability and Causal Associations Between Major Depressive Disorder and Cardiovascular Diseases
por: Zhang, Fuquan, et al.
Publicado: (2021)

Minor perturbations of thyroid homeostasis and major cardiovascular endpoints—Physiological mechanisms and clinical evidence
por: Müller, Patrick, et al.
Publicado: (2022)

Global eligibility and cost effectiveness of icosapent ethyl in primary and secondary cardiovascular prevention
por: Toth, Peter P., et al.
Publicado: (2023)

Karma of Cardiovascular Disease Risk Factors for Prevention and Management of Major Cardiovascular Events in the Context of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
por: Crisan, Liliana, et al.
Publicado: (2019)

Local and Distributed Machine Learning for Inter-hospital Data Utilization: An Application for TAVI Outcome Prediction
por: Lopes, Ricardo R., et al.
Publicado: (2021)

Utility of S100A12 as an Early Biomarker in Patients With ST-Segment Elevation Myocardial Infarction
por: Zhang, Xiaolin, et al.
Publicado: (2021)

The utility of ultrasound and computed tomography in the assessment of carotid artery plaque vulnerability–A mini review
por: Singh, Aniruddha, et al.
Publicado: (2022)

Renocardiovascular Biomarkers: from the Perspective of Managing Chronic Kidney Disease and Cardiovascular Disease
por: Niizuma, Shinichiro, et al.
Publicado: (2017)

The Utility of Cardiac Reserve for the Early Detection of Cancer Treatment-Related Cardiac Dysfunction: A Comprehensive Overview
por: Foulkes, Stephen, et al.
Publicado: (2020)

Utility of Human Immune Responses to GAS Antigens as a Diagnostic Indicator for ARF: A Systematic Review
por: Salie, M. Taariq, et al.
Publicado: (2021)

Corrigendum: Utility of S100A12 as an Early Biomarker in Patients With ST-Segment Elevation Myocardial Infarction
por: Zhang, Xiaolin, et al.
Publicado: (2022)

Utility of PREDICT-HF score in high-risk Asian heart failure patients receiving sacubitril/valsartan
por: Hsu, Chien-Yi, et al.
Publicado: (2022)

Analysing cardiovascular risk factors and related outcomes in a middle-aged to older adults population in Iran: a cohort protocol of the Shiraz Heart Study (SHS)
por: Zibaeenezhad, Mohammad Javad, et al.
Publicado: (2019)

Serum copper levels and risk of major adverse cardiovascular events: a systematic review and meta-analysis
por: Muñoz-Bravo, Carlos, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hn67t1kvld17ljdutj4fhm60sm